Search

Your search keyword '"Mediavilla, Joaquín Díaz"' showing total 4 results
Start Over Author "Mediavilla, Joaquín Díaz"
4 results on '"Mediavilla, Joaquín Díaz"'

1. Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial

Author

Mateos, María-Victoria, Oriol, Albert, Martínez-López, Joaquín, Gutiérrez, Norma, Teruel, Ana-Isabel, de Paz, Raquel, García-Laraña, José, Bengoechea, Enrique, Martín, Alejandro, Mediavilla, Joaquín Díaz, Palomera, Luis, de Arriba, Felipe, González, Yolanda, Hernández, Jose-Mariano, Sureda, Ana, Bello, José-Luis, Bargay, Joan, Peñalver, Francisco-Javier, Ribera, José-María, Martín-Mateos, María-Luisa, García-Sanz, Ramón, Cibeira, María-Teresa, Ramos, María-Luisa Martín, Vidriales, María-Belén, Paiva, Bruno, Montalbán, María-Angeles, Lahuerta, Juan-José, Bladé, Joan, and Miguel, Jesús-Fernando San

Published
2010
Full Text
View/download PDF

2. Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Results of the PETHEMA LPA2005 Trial Using All-Trans Retinoic Acid and Anthracycline with Cytarabine for High-Risk Patients

Author

Sanz, Miguel A., primary, Montesinos, Pau, primary, Holowiecka, Aleksandra, primary, Milone, Gustavo, primary, Rayon, Chelo, primary, de Lisa, Elena, primary, de la Serna, Javier, primary, Brunet, Salut, primary, Leon, Angel, primary, Krsnik, Isabel, primary, Rivas, Concha, primary, Ribera, Jose M., primary, Gonzalez, Jose, primary, Mediavilla, Joaquín Díaz-, primary, Bueno, Javier, primary, Gonzalez, Jose David, primary, Bergua, Juan, primary, and Gonzalez, Marcos, primary

Published
2008
Full Text
View/download PDF

3. Recommendations for the treatment of invasive fungal infection caused by filamentous fungi in the hematological patient.

Author

Barberán, José, Mensa, Josep, Llamas, Juan Carlos Vallejo, Ramos, Isidro Jarque, Ruiz, Juan Carlos García, Marín, José Rafael Cabrera, Tello, Patricia Baltasar, Massana, Montse Batlle, Vidal, Juan Besalduch, Viñas, José Manuel Calvo, Huelva, Francisco Javier Capote, Pons, Enric Carreras, Mediavilla, Joaquín Díaz, Morfa, Miguel L. Díaz, Avellán, Fernando Escalante Barrigón Pascual Fernández, López, Sebastián Garzón, García, Carlos Grande, Maraver, Dolores Hernández, de la Guía, Ana López, and Jiménez, Javier López

Subjects
MYCOSES, COMMUNICABLE disease treatment, ETIOLOGY of diseases, FILAMENTOUS fungi, ANTIFUNGAL agents, DEATH rate, MEDICAL specialties & specialists, CLINICAL trials
Abstract

Copyright of Revista Española de Quimioterapia is the property of Sociedad Espanola de Quimioterapia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2011

4. Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Results of the PETHEMA LPA2005 Trial Using All-TransRetinoic Acid and Anthracycline with Cytarabine for High-Risk Patients

Author

Sanz, Miguel A., Montesinos, Pau, Holowiecka, Aleksandra, Milone, Gustavo, Rayon, Chelo, de Lisa, Elena, de la Serna, Javier, Brunet, Salut, Leon, Angel, Krsnik, Isabel, Rivas, Concha, Ribera, Jose M., Gonzalez, Jose, Mediavilla, Joaquín Díaz-, Bueno, Javier, Gonzalez, Jose David, Bergua, Juan, and Gonzalez, Marcos

Abstract

Background: A previous report of the PETHEMA Group (Sanz et al, Blood 2004) showed that a risk-adapted strategy combining ATRA and anthracycline monochemotherapy for induction and consolidation (LPA99 trial), followed by ATRA and low dose methotrexate and mercaptopurine for maintenance therapy, resulted in high antileukemic efficacy, moderate toxicity, and a high degree of compliance. A critical analysis of this study led us to consider the following opportunities for improvement in a new trial:

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results